AU2001286418A1 - Stable pergolide mesylate and process for making same - Google Patents

Stable pergolide mesylate and process for making same

Info

Publication number
AU2001286418A1
AU2001286418A1 AU2001286418A AU8641801A AU2001286418A1 AU 2001286418 A1 AU2001286418 A1 AU 2001286418A1 AU 2001286418 A AU2001286418 A AU 2001286418A AU 8641801 A AU8641801 A AU 8641801A AU 2001286418 A1 AU2001286418 A1 AU 2001286418A1
Authority
AU
Australia
Prior art keywords
making same
pergolide mesylate
stable
stable pergolide
mesylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286418A
Other languages
English (en)
Inventor
Minutza Leibovici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2001286418A1 publication Critical patent/AU2001286418A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AU2001286418A 2000-08-08 2001-08-07 Stable pergolide mesylate and process for making same Abandoned AU2001286418A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22377400P 2000-08-08 2000-08-08
US60223774 2000-08-08
PCT/US2001/024713 WO2002011727A1 (fr) 2000-08-08 2001-08-07 Mesylate de pergolide stable et procede de fabrication correspondant

Publications (1)

Publication Number Publication Date
AU2001286418A1 true AU2001286418A1 (en) 2002-02-18

Family

ID=22837926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286418A Abandoned AU2001286418A1 (en) 2000-08-08 2001-08-07 Stable pergolide mesylate and process for making same

Country Status (8)

Country Link
US (1) US6689384B2 (fr)
EP (1) EP1318813A4 (fr)
JP (1) JP2004505917A (fr)
AU (1) AU2001286418A1 (fr)
CA (1) CA2418915A1 (fr)
HU (1) HUP0303355A3 (fr)
IL (1) IL154290A0 (fr)
WO (1) WO2002011727A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154290A0 (en) 2000-08-08 2003-09-17 Teva Pharma Stable pergolide mesylate and process for making same
WO2003080030A1 (fr) * 2002-03-26 2003-10-02 Bernard Charles Sherman Comprimes stables contenant du pergolide mesylate
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
MX2007001850A (es) * 2004-08-13 2007-03-28 Boehringer Ingelheim Int Formulacion de pildora de liberacion prolongada que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para fabricarlo y uso del mismo.
EP1781260B2 (fr) * 2004-08-13 2014-04-02 Boehringer Ingelheim International GmbH Formulation d'un tablet avec liberation prolongueé comprennant pramipexole ou un sel pharmaceutiquement acceptable, la methode de la fabrication et l'utilisation du formulation
CN101031322A (zh) * 2004-10-01 2007-09-05 日本脏器制药株式会社 固体药物制剂
TWM281293U (en) * 2005-05-06 2005-11-21 Harvatek Corp Optoelectronic chip array package structure
WO2007090883A1 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Formulation à libération prolongée
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
IL154290A0 (en) 2000-08-08 2003-09-17 Teva Pharma Stable pergolide mesylate and process for making same

Also Published As

Publication number Publication date
EP1318813A4 (fr) 2005-09-07
JP2004505917A (ja) 2004-02-26
EP1318813A1 (fr) 2003-06-18
US20020054904A1 (en) 2002-05-09
HUP0303355A2 (hu) 2004-01-28
HUP0303355A3 (en) 2005-06-28
WO2002011727A1 (fr) 2002-02-14
CA2418915A1 (fr) 2002-02-14
US6689384B2 (en) 2004-02-10
IL154290A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
AU2001236148A1 (en) Polyorganosilsesquioxane and process for preparing the same
AU2001266583A1 (en) Epothilone derivatives and methods for making and using the same
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2001286418A1 (en) Stable pergolide mesylate and process for making same
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001294354A1 (en) Process for making amlodipine, derivatives thereof, and precursors therefor
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2002241739A1 (en) Antimycobacterial compounds and method for making the same
AU2001295579A1 (en) Pants and method for the production thereof
AU7456101A (en) Process for producing hexafluoroethane and use thereof
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
AU2001276928A1 (en) Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU6730001A (en) Component, method for production and use thereof
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU2002211034A1 (en) Aziridinylquinolinedione derivatives and process for their preparation
IL151216A0 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
AU2001263505A1 (en) Heat-resistant formulation and method for using same
AU2001210580A1 (en) High-nicotine tobacco and process for producing the same
EP1213070A3 (fr) Procédé et dispositif pour la coulée de métal
AU2002360687A1 (en) Garments and apparatus and methods for making such garments
AU2002210689A1 (en) Process for preparing 5-amino-3-alkylisothiazoles and 5-amino-4-chloro-3-alkylisothiazoles